Pfizer and BioNTech asked the FDA to allow their coronavirus vaccine to be stored for 2 weeks at temperatures typical of conventional pharmaceutical freezers, which could facilitate distribution of the drug. The partners presented data showing the vaccine is stable at storage temperatures of -25 to -15 degrees Celsius. The companies will send similar appeals to other regulators in the coming weeks.